Yesterday was a long one but a huge step forward after so much uncertainty.
We know we are very lucky to have been able to access world class experts who have given an informed and considered opinion that Peter's recent heart attack was not due to Paclitaxol or Herceptin, they explained yesterday how they arrived at that decision .
The trial office said based on this opinion, Peter could be offered an opportunity to continue.
The final decision was his but he could continue on trial with same drugs and dose
Given that at last scan Peter was showing a good response, he decided he wanted to continue, he has a will of iron and I have to admire his determination to fight this all the way.
We both have complete confidence in his team who work tirelessly with us so openly and honestly.
Unfortunately It was extremely difficult to canulate Peter and he ended up with multiple dressings on his poor arms but eventually he commenced cycle 4 it was given very very slowly and thank fully he was fine.
The plan
Continue on trial until progression
Continue on split dose Tinzaparin
New PICC line will be placed next week as his veins are so difficult to access now
Then
06.05 14 Muga scan and CT Scan
07.05.14 Ct Angiography and a 24 Hour Holter Tape,
So the 18 hour day was a success and we fell into bed feeling we had pressed the reset button and managed with some heavy weight expertise to restart the journey.
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2025 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007